A Phase II Efficacy and Safety Study of HSK44459 in Subjects With Moderate to Severe Plaque Psoriasis
Clinical trial NCT07150988 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07150988
- Sponsor
- Haisco Pharmaceutical Group Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-09-26
- Primary completion
- 2026-11-06
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.